These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1173046)
21. Renal effects of continuous negative pressure breathing. Kinney MJ Aviat Space Environ Med; 1975 Nov; 46(11):1358-62. PubMed ID: 1212140 [TBL] [Abstract][Full Text] [Related]
22. Lithium clearance in patients with chronic renal diseases. Clericetti N; Beretta-Piccoli C Clin Nephrol; 1991 Dec; 36(6):281-9. PubMed ID: 1769139 [TBL] [Abstract][Full Text] [Related]
23. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus. Laczi F; Mezei G; Julesz J; Lázló FA Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552 [TBL] [Abstract][Full Text] [Related]
24. Natriuretic, diuretic and anti-arginine-vasopressin (ADH) effects of two analogs of oxytocin: [4-leucine]-oxytocin and [2,4-diisoleucine]-oxytocin. Chan WY; Du Vigneaud V J Pharmacol Exp Ther; 1970 Sep; 174(3):541-9. PubMed ID: 5456186 [No Abstract] [Full Text] [Related]
25. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation]. De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199 [TBL] [Abstract][Full Text] [Related]
26. Detection of renal impairment in cases of chronic abuse of analgesics by administration of desamino-D-arginine vasopressin. Wambach G; Bönner G; Kleinpass H; Dopatka A; Kaufmann W Arzneimittelforschung; 1989 Mar; 39(3):387-90. PubMed ID: 2569306 [TBL] [Abstract][Full Text] [Related]
27. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus]. Lebacq E; David L Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251 [No Abstract] [Full Text] [Related]
28. A comparison of some activities of arginine vasopressin and lysine vasopressin on kidney function in conscious dogs. ALI MN Br J Pharmacol Chemother; 1958 Jun; 13(2):131-7. PubMed ID: 13536276 [TBL] [Abstract][Full Text] [Related]
29. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [TBL] [Abstract][Full Text] [Related]
30. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin. Czakó L; Mezei G; László FA Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863 [TBL] [Abstract][Full Text] [Related]
31. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability]. Tuschy U; Szeszat S; Rindfleisch U Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171 [TBL] [Abstract][Full Text] [Related]
32. Effects of antidiuretic hormone on urinary acidification and on tubular handling of bicarbonate in the rat. Bichara M; Mercier O; Houillier P; Paillard M; Leviel F J Clin Invest; 1987 Sep; 80(3):621-30. PubMed ID: 3624481 [TBL] [Abstract][Full Text] [Related]
33. Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidus. Radó JR; Szende L; Marosi J Metabolism; 1974 Nov; 23(11):1057-63. PubMed ID: 4214480 [No Abstract] [Full Text] [Related]
34. Loss of renomedullary interstitial cells in Brattleboro rats after vasopressin treatment. Sundelin B; Bohman SO Lab Invest; 1988 Apr; 58(4):388-94. PubMed ID: 3357333 [TBL] [Abstract][Full Text] [Related]
35. [Possible mechanisms of polyuria in progressive chronic renal failure]. Natochin IuV; Bogolepova AE Ter Arkh; 2000; 72(6):15-20. PubMed ID: 10900642 [TBL] [Abstract][Full Text] [Related]
36. The effects of functional adaptation of residual nephrons on the urinary excretion of drugs. Schück O; Nádvorníková H; Grafnetterová J; Prát V Yale J Biol Med; 1978; 51(3):351-4. PubMed ID: 735157 [TBL] [Abstract][Full Text] [Related]
37. [Side differences in renal electrolyte elimination in asymmetrical chronic pyelonephritis and its analysis]. Ludwig H Klin Wochenschr; 1968 Apr; 46(8):424-31. PubMed ID: 5686114 [No Abstract] [Full Text] [Related]
38. [Importance of residual diuresis in patients with chronic pyelonephritis under constant dialysis treatment]. Erben J Z Urol Nephrol; 1977 Jan; 70(1):51-8. PubMed ID: 848145 [TBL] [Abstract][Full Text] [Related]
39. [Experimental study on the relations between ovarian function and diuresis. VI. Effect of progesterone on diuresis, elimination of urinary chlorides and response to pitressin, in the castrated rabbit subjected to the test of water load]. OGIER E; MORICHI G Riv Ostet Ginecol; 1956 Jan; 11(1):40-50. PubMed ID: 13324012 [No Abstract] [Full Text] [Related]
40. MODIFICATION OF THE ANTIDIURETIC EFFECT OF VASOPRESSIN BY ACID AND ALKALINE LOADS. ULLMANN TD; CZACZKES WJ; MENCZEL J J Clin Invest; 1965 May; 44(5):754-64. PubMed ID: 14276133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]